Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Below averageWe are a consumer-first health and wellness platform focused on providing access to modern personalized health and wellness solutions to consumers. We offer access to a range of health and wellness products and services available for customers to purchase through our websites and mobile applications. The offerings generally focus on conditions where treatment typically involves use of prescription medication on a recurring basis and ongoing care from healthcare providers.
In the company’s own words · 10-K filed Feb 23, 2026 · SEC EDGAR
Business segments
Q2 2026 · $753.2MThe company’s own SEC segment disclosure.
- United States$621.8M83%
- Non Us$131.4M17%
Hims & Hers Health, Inc. (HIMS) reported revenue of $753M in Q2 2026 (quarter ended Jun 30, 2026), up 38% from the same quarter a year earlier. That came with a gross margin of 64% and net loss of $86M. For the full year FY2025, revenue was $2.35B (+59% year on year) and net income $128M. Its largest region in Q2 2026 was United States at $622M, 83% of the disclosed total, well ahead of Non Us at 17%.
Raw charts
10 series · TTMAs reported to the SEC, without any scoring.
Drug Manufacturers - Specialty & Generic
Ranks #21 of 29 by Smart Score